Literature DB >> 26520713

Optimization of the fractionated irradiation scheme considering physical doses to tumor and organ at risk based on dose-volume histograms.

Yasutaka Sugano1, Masahiro Mizuta2, Seishin Takao3, Hiroki Shirato3, Kenneth L Sutherland3, Hiroyuki Date4.   

Abstract

PURPOSE: Radiotherapy of solid tumors has been performed with various fractionation regimens such as multi- and hypofractionations. However, the ability to optimize the fractionation regimen considering the physical dose distribution remains insufficient. This study aims to optimize the fractionation regimen, in which the authors propose a graphical method for selecting the optimal number of fractions (n) and dose per fraction (d) based on dose-volume histograms for tumor and normal tissues of organs around the tumor.
METHODS: Modified linear-quadratic models were employed to estimate the radiation effects on the tumor and an organ at risk (OAR), where the repopulation of the tumor cells and the linearity of the dose-response curve in the high dose range of the surviving fraction were considered. The minimization problem for the damage effect on the OAR was solved under the constraint that the radiation effect on the tumor is fixed by a graphical method. Here, the damage effect on the OAR was estimated based on the dose-volume histogram.
RESULTS: It was found that the optimization of fractionation scheme incorporating the dose-volume histogram is possible by employing appropriate cell surviving models. The graphical method considering the repopulation of tumor cells and a rectilinear response in the high dose range enables them to derive the optimal number of fractions and dose per fraction. For example, in the treatment of prostate cancer, the optimal fractionation was suggested to lie in the range of 8-32 fractions with a daily dose of 2.2-6.3 Gy.
CONCLUSIONS: It is possible to optimize the number of fractions and dose per fraction based on the physical dose distribution (i.e., dose-volume histogram) by the graphical method considering the effects on tumor and OARs around the tumor. This method may stipulate a new guideline to optimize the fractionation regimen for physics-guided fractionation.

Entities:  

Mesh:

Year:  2015        PMID: 26520713     DOI: 10.1118/1.4931969

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  5 in total

1.  Optimization of radiotherapy fractionation schedules based on radiobiological functions.

Authors:  Fernando Pizarro; Araceli Hernández
Journal:  Br J Radiol       Date:  2017-08-22       Impact factor: 3.039

2.  Technical Note: Break-even dose level for hypofractionated treatment schedules.

Authors:  Till Tobias Böhlen; Jean-François Germond; Jean Bourhis; Marie-Catherine Vozenin; Claude Bailat; François Bochud; Raphaël Moeckli
Journal:  Med Phys       Date:  2021-10-22       Impact factor: 4.506

3.  Comparison of the average surviving fraction model with the integral biologically effective dose model for an optimal irradiation scheme.

Authors:  Ryo Takagi; Yuriko Komiya; Kenneth L Sutherland; Hiroki Shirato; Hiroyuki Date; Masahiro Mizuta
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

4.  4-Methylumbelliferone administration enhances radiosensitivity of human fibrosarcoma by intercellular communication.

Authors:  Ryo Saga; Yusuke Matsuya; Rei Takahashi; Kazuki Hasegawa; Hiroyuki Date; Yoichiro Hosokawa
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

5.  Selection of external beam radiotherapy approaches for precise and accurate cancer treatment.

Authors:  Hiroki Shirato; Quynh-Thu Le; Keiji Kobashi; Anussara Prayongrat; Seishin Takao; Shinichi Shimizu; Amato Giaccia; Lei Xing; Kikuo Umegaki
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.